Wells Fargo
TVGN icon

Wells Fargo’s Tevogen Bio Holdings TVGN Stock Holding History

Wells Fargo’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.41K Sell
311
-599
-66% -$7.34K ﹤0.01% 6296
2025
Q4 		$15.1K Buy
910
+503
+124% +$13.1K ﹤0.01% 5865
2025
Q3 		$16K Buy
407
+83
+26% +$4.08K ﹤0.01% 5848
2025
Q2 		$20.3K Buy
324
+77
+31% +$4.39K ﹤0.01% 5790
2025
Q1 		$13.3K Buy
247
+11
+5% +$724 ﹤0.01% 5821
2024
Q4 		$12.1K Buy
236
+68
+40% +$4.43K ﹤0.01% 5895
2024
Q3 		$3.09K Buy
168
+5
+3% +$146 ﹤0.01% 6005
2024
Q2 		$5.89K Buy
+163
New +$10.6K ﹤0.01% 5845

Other funds holding TVGN

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Wells Fargo's TVGN Position: Q1 2026 in Review

Wells Fargo reduced its Tevogen Bio Holdings (TVGN) stake by 66% in Q1 2026, selling an estimated $7.34K and leaving 311 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #6296.

Wells Fargo first reported a position in TVGN in Q2 2024 and has held it in 8 quarters since. The position peaked at $20.3K in Q2 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

  • Wells Fargo held 311 shares of Tevogen Bio Holdings worth $1.41K as of Q1 2026.
  • Wells Fargo sold 599 Tevogen Bio Holdings shares in Q1 2026, an estimated $7.34K.
  • Tevogen Bio Holdings made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6296 holding.
  • Wells Fargo first reported a position in Tevogen Bio Holdings in Q2 2024 and has held it in 8 quarters since.
  • Wells Fargo's Tevogen Bio Holdings position peaked at $20.3K in Q2 2025.
  • 30 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.